Jul 10, 2017 11:56 am UTC| Business
Lausanne, Switzerland, July 10, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that seven updates on the advancement of...
BOK Financial Announces Second Quarter 2017 Earnings Conference Call
Jul 10, 2017 11:50 am UTC| Business
TULSA, Okla., July 10, 2017 -- BOK Financial Corporation (NASDAQ:BOKF) today announced that financial results for the second quarter of 2017 will be released before market open on Wednesday, July 26, 2017. The company...
Cesca Therapeutics Acquires the Cell Processing Systems of SynGen Under Asset Acquisition Agreement
Jul 10, 2017 11:45 am UTC| Business
RANCHO CORDOVA, Calif., July 10, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that its wholly-owned...
Harbin Clinic to Launch Personalized Mental Health Program Utilizing MYnd Analytics PEER Registry
Jul 10, 2017 11:30 am UTC| Business
ROME, Ga., July 10, 2017 -- MYnd Analytics, Inc. ("MYnd") (OTCQB:MYAN), and Harbin Clinic are teaming up to provide personalized care to patients in mental health care with the implementation of PEER Online™ at Harbin...
McDermott Announces Date for Second Quarter 2017 Financial Results and Conference Call
Jul 10, 2017 11:30 am UTC| Business
HOUSTON, July 10, 2017 -- McDermott International, Inc. (NYSE:MDR) will report financial results for the second quarter of 2017 on Tuesday, July 25, 2017. President and Chief Executive Officer David Dickson and...
Sky Solar Announces Appointment of Naiwei Chen to Board of Directors
Jul 10, 2017 11:30 am UTC| Business
HONG KONG, July 10, 2017 -- Sky Solar Holdings, Ltd. (NASDAQ:SKYS) (“Sky Solar” or the “Company”), a global developer, owner and operator of solar parks, today announced that Mr. Naiwei Chen was appointed as an...
Cesar Millan to Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews
Jul 10, 2017 11:30 am UTC| Business
OTTAWA, July 10, 2017 -- Avivagen Inc. (“Avivagen” or the “Corporation” (TSX-V:VIV) (OTC Pink:CHEXF), a life sciences innovation company with a series of patent protected products that support and optimize health,...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight